Latest News

Wide U.S.-Europe natural gas spreads are boosting fertilizer margins. CF Industries, CVR Partners, and LSB Industries all trade below their spring highs despite strong spread economics.

Apple is beating the market this year, but a stock beating Apple's return has a higher yield than the seven "Magnificent Seven" stocks combined.

The once-hot streaming stock has been falling sharply this year due to concerns around engagement.

It all comes down to portfolio construction -- one is logical, one isn't.

The cannabis company is set to report its earnings early next month.

Performance in the last decade is well above the benchmark's historical average.

Dell's potential AI server pipeline suggests the company is on track to deliver phenomenal growth over the next five years.

Lucid burns cash faster but trades cheaper. Rivian has deeper pockets and a VW partnership. But both face a brutal path to profitability.

D.R. Horton, CAVA, and FTAI Aviation announced major buyback programs after share price declines, with D.R. Horton raising 2026 repurchase guidance 30% amid housing headwinds.

Taking a basket approach to quantum stocks makes sense.

The new "fast track" inclusion rules mean that Anthropic could show up in ETFs just a few days after going public.

A “Trump bump” and the AI revolution should lead to considerably larger Social Security checks in 2027.

Upstart, Sezzle, and Intuitive Machines show strong growth in niche markets, with rising revenue and demand, though each faces distinct risks like valuation, short interest, or cash burn.

JPMorgan, McDonald's, and VICI Properties raised dividends despite recent share-price weakness, with payout ratios suggesting each increase remains well supported by earnings and cash flow.

Tesla's sky-high valuation sets the stage for a significant potential correction.

High-yield savings accounts are looking even better after the Fed's latest hike. See what counts as a good rate, plus what else to do with your cash today.

The stock market has been rallying for more than three years, but smart investors know the music won't go on forever.

Despite dominating the home improvement market, this company has been operating from a position of fundamental weakness.

Snowflake stock amid a $3.5 billion convertible debt offering amid investor concerns over potential equity dilution down the line.

Cullinan Therapeutics (NASDAQ:CGEM) outlined upcoming clinical milestones across its immunology and oncology pipeline, including a planned December update for its CD19-directed T-cell engager CLN-978 and data presentations for other programs in November and the fourth quarter. President and CEO Nad

Investors are bullish on Palantir's stock due to not only the company's strong growth but also a convincing vision from CEO Alex Karp.